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Abstract 
 
Peripheral vascular disease (PVD) is a chronic disabling illness that frequently results in 
the occlusion of arteries in lower limbs and may cause ischemia, gangrene, or infection.  
The single most significant factor contributing to both the onset and progression of PVD 
is smoking, which has addictive properties.  Once smoking becomes a habitual behavior, 
combined with the atherosclerotic process, a disastrous pathway ensues.  The aim of this 
project was to gain an understanding of the beliefs of patients with PVD who smoked.  
Data were obtained from a sample of participants with a known history of PVD who have 
had a previous vascular intervention and who are established patients in a vascular 
surgeon’s private office where N=50. The majority of participants were male (n=31; 
63%) 65-74 years of age (n=18; 36%), were unemployed (n=30; 60%) and have smoked 
for greater than 51+ years (n=13; 26%).  A scale that was developed guided by The 
Behavioral beliefs subscale revealed that PVD patients enjoyed smoking, smoking helped 
them to relax, and that they believed that they were addicted to smoking.  Results from 
the normative beliefs indicated that the spouse or significant other, children or those 
whom they lived with, did not approve of their smoking and also that their healthcare 
provider had discussed smoking cessation with them.  The control beliefs subscale results 
demonstrated that most patients had attempted to quit smoking, believed it would be a 
difficult behavior to stop, believed that they would require the assistance of a patch or 
medication and feared the withdrawal symptoms.   Exploring the beliefs and thought 
process of patients who smoked provided a rich body of knowledge which can afford the 
healthcare professional with the ability to better understand the smoking experience as 
seen through patients’ eyes. 
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IDENTIFYING BELIEFS ABOUT SMOKING IN PATIENTS WITH PERIPHERAL 
VASCULAR DISEASE  
Background/Statement of the Problem 
Peripheral vascular disease (PVD), also known as arteriosclerosis obliterans, 
refers to the occlusion or stenosis of arteries, usually occurring in the lower extremities.  
This devastating disease can lead to loss of limb or even death.  Between 5% and 10% of 
Americans, who are 40 years of age or older, are affected with PVD; of those, 40% are 
smokers. (Hennrikus et al., 2010)  In these atherosclerotic arteries, a cholesterol/protein 
core called an atheroma gradually enlarges stenosing or occluding medium and large 
vessels.  If the diameter of the artery is reduced by 50%, this can lead to alterations in 
distal pressures afforded to affected muscle groups (Hennrikus et al., 2010).  This 
ischemia results from atherothrombosis of the distal aorta and it’s branching, causing 
intermittent claudication, rest pain, skin ulcerations, and even gangrene. (Creager, 
Kaufman, & Conte, 2012)      
The symptoms of PVD can appear as early as the patient’s fifth decade of life, but 
usually do not become problematic until the patient experiences difficulty in ambulation 
or exercise intolerance (Hughson, Mann, & Garrod, 1978).  Typically, while at rest, 
blood flow is normal.  At the onset of the disease process, these symptoms appear while 
ambulating for some distance, climbing stairs, or even with mild exercise. The proximal 
stenosis caused by the atherosclerotic process results in the affected arteries’ inability to 
meet the metabolic blood demands of the distal muscles, subsequently leading to tissue 
ischemia manifesting in a cramping muscle pain (Powell, 1998).  When the patient rests 
and ceases exercise, blood supply reaches muscles and pain then subsides.  Peripheral 
vascular disease left untreated can severely debilitate a patient, and in some cases cause 
life threatening infections.   
Numerous risk factors can affect atherosclerosis.  Many of these factors can be 
modified, others cannot.  Aging and family history of early heart disease are not 
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modifiable risk factors.  Hypertension, obesity, diabetes, hyperlipidemia, sedentary 
lifestyle, and significantly smoking are risk factors that can be controlled or prevented.  
In this respect, smoking is both the disease and the cause of the disease (Powell, 1998).   
In 1965, reports of the Surgeon General mandated Congress to require all 
cigarette packages distributed in the United States carry a health warning label.  
Consequently, by September of 1970 cigarette advertising was banned on television and 
radio.  The anti-smoking campaign had begun.  Almost 50 years later, society is well 
aware of the dangers of smoking.  Most individuals can associate the use of tobacco with 
the development of cancer.  Some individuals are concerned and quit, while others hear 
the warning and continue to smoke.  Of particular interest are vascular patients who often 
appear to be unaware of the correlation between nicotine and atherosclerosis.  Familiar 
anti-smoking campaigns in the media have traditionally focused on smoking’s 
carcinogenic affects and not the destruction of the patients’ vasculature. 
Countless research studies are available regarding nicotine use and 
atherosclerosis.  This disastrous combination is often what brings the vascular patient to 
seek a surgical intervention due to the onset of claudicant pain.  Lack of recognition of 
this association between smoking and arterial stenosis can lead to repeated surgical 
interventions.  This manifestation requires exploration due to the fact that for some 
individuals, even after repeated vascular interventions and multiple return visits to the 
vascular surgeon’s office, the smoking habit continues.  The key question to address is:  
what are the driving factors that cause a vascular patient to continue to smoke- habit, 
addiction, peer pressure, or the smoking experience itself? 
The purpose of this project is to identify the behavioral, normative, control beliefs 
of patients with PVD toward smoking.  Next, the review of the literature will be 
presented. 
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Literature Review 
Articles related to patient smoking and vascular disease were obtained from 
searches in PubMed, CINHAL, and Cochrane databases using the free text phrase 
“nicotine use and atherosclerosis”, which resulted in over 200 articles.  Additional 
searches using the MeSH term “vascular patient and smoking”, “nicotine”, 
“atherosclerosis”, and “smoking cessation” returned several relevant results.  In addition, 
the Theory of Reasoned Action (TRA) and the Theory of Planned Behavior (TPB) were 
explored using the mentioned data bases and resulted in numerous research articles on 
application of the TRA/TPB to smoking behavior. 
Epidemiology of Smoking 
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According to the World Health Organization (WHO) estimates, there are 1.1 
billion tobacco smokers worldwide, constituting one third of the adult population.  The 
majorities of smokers are seen in developed countries and are estimated at 800 million.  
The vast majority of smokers are male (67%), with females constituting 33% 
(Fagerstrom, 2002).  World-wide, tobacco use has resulted in more than 5 million adult 
deaths annually, with the largest numbers seen in the United States and Europe 
(Fagerstrom).   
Another recent trend is the increased numbers of young smokers.  In 1992, in the 
United States, 17% of all high school seniors smoked, while this number increased to 
22% by 1995. Assuming these staggering numbers will continue to rise, it is estimated 
that by 2030, worldwide smokers will increase to 1.6 billion, with a corresponding 
increase in tobacco related diseases and deaths (Fagerstrom, 2002). 
Weinberger et al. (2014) performed a longitudinal investigation of smoking status 
that demonstrated an annual average of 480,000 tobacco-related deaths in the United 
States.  This number has increased steadily in the last 50 years.  With these staggering 
statistics, tobacco is predicted to be the leading cause of death by 2020, resulting in one 
in every eight deaths.  Smokers will die prematurely secondary to tobacco-use related 
diseases.   
 State-specific prevalence of current smoking surveyed in 2013 revealed that 20% 
of Rhode Island (RI) residents smoke.  This number decreased slightly in 2013 to 17.4%, 
but the increased number of smokeless tobacco use increased by 1.4%, which offsets this 
data (Nguyen, Marshall, Hu, & Neff, 2015).   
The Center for Disease Control (CDC) reported that only one in seven 
individual’s attempted quitting smoking during a 3-year period.  The stability of the 
smoking rate is not related to the smokers desire to quit or a lack of smoking cessation 
attempts; the majority of cessation attempts end in relapse (Weinberger, Pilver, Mazure, 
& McKee, 2014). 
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Hazards of Smoking 
Numerous research articles have been published on the hazards of cigarette 
smoking.  The association between smoking and premature death has been established 
(Powell 1998).    Varying complications result from smoking such as lung cancer, 
respiratory disease, cardiovascular complications, as well as peripheral atherosclerosis.  
Powell discussed vascular damage of the arterial wall from smoking and how nicotine 
specifically alters the cellular DNA.  She focused on three separate stages of how 
smoking potentiates the development of atherosclerosis:  endothelial dysfunction, 
monocyte recruitment and development of plaque, and thrombus at the damages of the 
arterial intima. 
The combustion of tobacco in cigarettes releases hundreds of different chemicals 
including aromatic hydrocarbons, aromatic amines, carbon monoxide, nitrogen oxides, 
and nicotine.  These hazardous chemicals interfere with a variety of cellular and 
metabolic process.  Of these chemicals, nicotine has the most additive properties 
(Powell). 
Ambrose and Barua (2004) summarized the pathophysiology of cigarette smoking 
and cardiovascular disease. They extensively elaborated on the cause of endothelial 
dysfunction of smoking to acute clinical events.  The results connected cigarette smoking, 
more specifically, the exposure of nicotine, which predisposes individuals to several 
different atherosclerotic syndromes, coronary artery disease, and stroke, including aortic 
and peripheral atherosclerosis leading to intermittent claudication and abdominal aortic 
aneurysms.   
Ambrose and Barua also examined clinical and experimental observation between 
cigarette smoking and thrombosis.  In pathologic studies of sudden coronary death, 
cigarette smoking increased the risk of plaque rupture and acute thrombosis.  Platelets 
isolated from smokers also revealed stimulated spontaneous aggregation and adhesion, 
proving platelet dysfunction.  Smokers have higher fibrinogen levels altering tissue factor 
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pathways, increasing thrombotic potential.   Nicotine also affects substance-P-stimulated 
t-PA.  This alteration of fibrinolysis causes dysfunctional thrombohemostatic 
mechanisms that promote the initiation and propagation of thrombus formation and 
inhibits its effective dissolution (Ambrose & Barua).   
In addition, reviewing the nicotine effects of atherosclerotic changes in a vessel, 
Ambrose and Barua correlated the association of packs smoked per year with the severity 
of atherosclerosis.  The results indicated that either passive or active exposure to nicotine 
promoted vasomotor dysfunction, atherogenesis, and thrombosis in multiple vascular 
beds.  The authors concluded that even though the association between cigarette smoking 
and cardiovascular risk are extensively documented, the linear dose effect is unclear.  It 
was previously thought that the heavier the smoker, the higher cardiovascular risks.  
Newer data is suggestive of a non-specific dose-dependent correlation between heavy and 
light smokers (Ambrose & Barua).  Information now has been presented that supports 
that the underlying biochemical and cellular processes may become saturated even with a 
small amount of toxic components of smoking (Ambrose & Barua).      
Nicotine Addiction 
Hatsukami, Stead, and Gupta (2008) conducted a seminar which focused on 
existing meta-analyses on treatments for smoking cessation and additionally, undertook a 
Medline search for articles related to drug treatments which were not included in the 
meta-analyses. Using Medline, the authors applied the following search terms:  “smoking 
cessation”, “tobacco cessation”, “nicotine replacement therapy”, and “antidepressants” 
among other several other terms to provide a comprehensive search.  Only studies with 
sufficient sample size and rigorous methodology were selected as additional studies. The 
seminar provided descriptions for the diagnosis of tobacco addiction, the biobehavioral 
basis for addiction and evidence based treatments 
Hatsukami et al. reviewed the criteria for nicotine dependence as described in the 
Diagnostic and Statistical Manual IV (DSM-IV) and the International Classification of 
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Diseases, 10th revision (IDC-10).  The DSM-IV and ICD-10 have been shown to have 
little predictive validity regarding relapse to smoking (Hatsukami et al.). The most widely 
used dependence measure is the Fagerstrom tolerance questionnaire.  The evidence 
suggested regardless of diagnostic criteria for nicotine dependence, all smokers should be 
provided with treatment for smoking cessation (Hatsukami et al.). 
The authors also reviewed the biobehavioral basis for addiction and found the 
physician and other health care professionals have a powerful effect in helping smokers 
to stop using tobacco.  Although over 45% of smokers will try to quit on their own 
yearly, less than 5% of them succeed (Hatsukami et al.).  Physicians and other healthcare 
professionals can have a powerful effect to enhance smoking cessation rates by as much 
as five-fold.  The authors found evidence that supported even just brief advice by health-
care professionals increased (2.5%) absolute rate of smoking cessation compared to no 
advice.  On average, in the USA about 70% of smokers seek healthcare and the authors 
suggested that this would be an excellent opportunity to provide effective treatments 
during office time.  Also, counseling frequently involves education regarding the 
beneficial health effects of smoking cessation, as well as, problem-solving, skills training 
and social support are important but require additional factors.  The use of a telephone 
quit line has proven beneficial when support is unavailable (Hatsukami et al.). 
Hatsukami et al. reviewed evidence-based treatments, including 
pharmacotherapies.  Nicotine replacement therapy (NRT) such as gum, lozenges, patches 
or sublingual tablets revealed positive results.  In RCTs comparing nicotine replacement 
therapies (NRTs) versus placebo, a 12-week continuous abstinence rate varied from 20%-
24%.  The mean quit rate at the six month mark for non-prescription NRTs was 7%.  The 
authors also performed an analysis to include bupropion and varenicline, two non-
nicotine-based drugs also used as anti-depressants.  These medications function as non-
competitive antagonist of the nicotinic acetylcholine receptor by blocking the reuptake of 
dopamine and noradrenaline.  Varenicline is a potent alpha-4 beta-2 partial agonist, 
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which provides tobacco withdrawal relief by its agonist action and blocks the reinforcing 
effects of nicotine by its antagonist action. Literature regarding combined therapies was 
also evaluated.  Nicotine replacement therapies provide a steady concentration of nicotine 
throughout the day and bupropion/varenicline provides tobacco withdrawal relief.  In 
these studies, smoking abstinence rates were 23% at six months when NRTs were 
combined with an anti-depressant, as opposed to only 10% of abstinence rates when 
NRTs were used alone.  These numbers only reflect short-term abstinence; long-term 
ratings only sustained a 4% margin in some studies (Hatsukami et al.). 
Although available pharmacotherapies can improve success rates, the absolute 
success rate remains fairly low (20%) (Hatsukami et al.).  The authors expressed that 
nicotine/tobacco addiction should be treated as a chronic disorder and that relapse should 
be seen as a probable event.  Treatment should be multi-therapy combining counseling 
with pharmacotherapy.  The consensus of the additional studies reviewed by Hatsukami 
et al. was that development of a comprehensive treatment program, encompassing 
multifaceted treatments, is required to treat tobacco addiction. 
Benowitz (2009) conducted a comprehensive review of the neurobiology of 
nicotine addiction and withdrawal, as well as the implications for nicotine addiction 
therapy.   Included was a review of the pharmacology of nicotine, the addictive 
properties, smoking-induced disease and therapeutics with an emphasis on individuals’ 
potential vulnerability to tobacco dependence.  Benowitz noted that with repeated 
exposure to nicotine, tolerance, or neuroadaptation, developed to some, but not all, of the 
effects of nicotine.  Neuroadaptation was associated with an increase in the number of 
nAChRs binding sites in the brain, which are believed to play a role in tolerance and 
dependence.  Smokers unknowingly continue to smoke throughout the day to maintain 
plasma levels and prevent withdrawal symptoms (Benowitz).  These withdrawal 
symptoms are associated with negative emotional states and may include anxiety and 
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perceived increased stress levels.  These represent a powerful stimulus to relapse to 
tobacco use (Benowitz).  
Benowitz (2009) described conditioned behavior and nicotine.  The author stated 
that all drug-taking behavior is learned, as a result of conditioning.  This behavior is 
reinforced by the pharmacologic actions of nicotine.  Concurrently, as this reaction is 
occurring, smokers begin to associate certain moods or situations related to the reward 
effects of nicotine.   The association between such cues and anticipated drug effects helps 
maintain the desire to smoke (Benowitz).  People often smoke cigarettes in specific 
situations, like after a meal, with a cup of coffee or alcoholic beverage, or out with 
friends who also smoke.  The association between smoking and these events repeated 
over time become powerful cues for the urge to smoke.  Even unpleasant moods can 
become conditioned cues for smoking.  A smoker may learn that not having a cigarette 
provokes irritability and smoking a cigarette provides relief (Benowitz).   
Nicotine underlies addiction and sustains cigarette smoking; therefore considering 
nicotine replacement as a potential alternative to tobacco use for smokers who cannot 
quit may be an option (Benowitz, 2009).  Nicotine replacement therapy has been shown 
to reduce smoking and increase smoking cessation rates.  Nicotine as a substitute for the 
thousands of carcinogenic toxins in cigarettes can be beneficial, but with prolonged 
exposure to nicotine other risk factors such as, cardiovascular system effects can promote 
atherogenesis and precipitate acute ischemic events in patients with PVD (Benowitz).   
Benowitz (2009) concluded that personalizing nicotine addiction treatment is the 
key to facilitating smokers to quit.  Most smokers are aware of the dangers of smoking 
and how it can affect organs throughout the body.  Quitting at any age may lead to 
significant reductions of smoking-related risk factors.  Despite these facts, approximately 
80% of smokers relapse within a few months of abstinence and only 3% remain abstinent 
three months out (Benowitz, 2009). 
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In 2010, Benowitz examined nicotine addiction via an extensive review.  
Benowitz noted that 45 million Americans smoke, 70% of smokers would like to quit, 
40% of smokers quit for one day.  Eighty percent of those that do quit return to smoking 
within one month, with about 3% successfully quitting smoking.  Benowitz found that 
when a smoker inhales smoke particles from a cigarette, nicotine enters the arterial 
circulation and moves in six seconds from lungs to brain and binds to nicotinic 
cholinergic receptors.  Stimulation of these receptors then stimulates a variety of 
neurotransmitters in the brain.  One of these is dopamine, an enzyme that triggers a 
pleasurable experience (Benowitz).   
Benowitz (2010) concluded that nicotine sustains tobacco addition by inducing 
pleasure as well as reducing stress and anxiety.  Smoking also has shown to improve 
concentration, reaction time, and enhance performances of certain tasks.  Smoking 
cessation even for just a few hours causes withdrawal symptoms which commonly 
include irritability, depressed mood, restlessness, and anxiety.  These withdrawals 
symptoms are often severe and to alleviate them smokers return to smoking.  Smokers 
relate specific moods and cues to smoking. Understanding the mechanism can lead to the 
development of novel medication and smoking-cessation treatment (Benowitz).  
Current Strategies in Smoking Cessation 
Gorin and Heck (2004) performed a meta-analysis of  research conducted 
between 1990 to 2004 using Medline, CINAH, PSYCINFO and dissertation abstracts 
related to  the efficacy of tobacco counseling by health care providers.  Over 200 articles 
were reviewed and of those 37 RCTs or quasi-experiments were selected.  Since 
healthcare professionals can greatly influence patients’ behavior, Gorin and Heck aimed 
to examine which providers were more effective:  physicians, nurses, dentists, or 
multiprovider teams.  
All RCTs or quasi-experiments utilized in-person counseling.  Times varied from 
3-5 minutes during a routine visit to structural behavioral change cessions lasting over an 
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hour.  Various counseling approaches were provided ranging from teaching patients to 
problem solve, relaxation methods, providing social support, education on the health 
dangers of smoking, or helping patients access intra-treatment or extra-treatment support. 
Studies had a mean sample size of 507 clients, with 239 in the intervention arm 
and 268 in the control arm.  Sixty-eight percent of the studies (n=25) assigned patients to 
the intervention arm or control arm at random, although several (n=32) assigned 
treatment by patient number or by using a quasi-experimental design.   The majority of 
the studies (76%; n=28) recruited subjects from in an out-patient or hospital visit, and the 
remainder (24%; n=9) were in an inpatient setting.  Ninety-seven percent (n=36) of the 
interventions included counseling. One percent of the studies (n=9) included mailed 
materials that were followed up with contact from a health care provider.  Approximately 
half of the participants (n=50) received follow-up by telephone, while the remainder 
(n=50) were followed up during a clinical visit.  The interventionists were divided by 
physicians (64%), nurses (72%), dentists (100%) and team approached accounted for 
64% of the studies.  Data revealed that patients surveyed reported that between 34%-74% 
received cessation advice from their provider.  Of these providers, 45%-85% were 
physicians, 36%-71% were nurses and 51%-61% were dentists.  
Gorin and Heck concluded that receiving even limited form of advice from any 
healthcare provider produced a small increase in smoking cessation rates.  Physicians 
(Effect Size = 6.01; 95% Confidence Interval, -2.46 to 13.29; P = 0.002) had higher 
smoking cessation rates, followed by dentists (Effect Size = 0.33; 95% Confidence 
Interval, -0.02 to 1.16; P = 0.12), then multi-provider teams (ES = 0.79%; 95% CI, -0.19 
to 3.71, P = 0.002), and finally, by nurses (ES = 0.03; 95% CI, -0.30 to 0.31; P = 0.37).    
Wu et al. (2006) conducted a meta-analysis regarding the effectiveness of 
pharmacological smoking cessation therapies.  The authors’ primary outcome of interest 
was smoking cessation at one year.  Findings included the following:  Odds Ratio (OR) 
1.71, 95%, Confidence Interval (CI) 1.55-1.88, P = < 0.0001. Their secondary point of 
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interest was smoking cessation at the three month interval.  Wu et al. searched 10 reliable 
electronic data bases including but not limited to MEDLINE, EMBASE, CINAHL, 
TOXNET, and Cochrane.  They conducted a meta-analysis of over 70 randomized 
controlled trials (RCTs) evaluating smoking cessation interventions at the one year mark.   
The inclusion criteria utilized only RCTs that used chemical confirmation as evidence of 
nicotine abstinence as an outcome.  False reporting is most likely to occur in the trial 
setting or in assessing smoking status after a medical event.  In both situations the smoker 
is under a considerable about of pressure to quit.  Laboratory tests are, often used to 
verify smoking cessation, especially in verification in clinical trials.  Only studies with 
the following chemical confirmation were utilized. Chemical confirmation included 
various methods of verifying smoking status including serum and saliva thiocyanate, 
expired carbon monoxide, plasma, saliva and urinary cotinine and nicotine.  This data 
was not reported as it was simply used as a confirmation of smoking status.  
 Wu et al. (2006) also examined several RCTs regarding the use of 
pharmacological interventions.  The three interventions included nicotine replacement 
therapy (NRT) (49 RCTs, OR 1.78, 95% CI, 1.60-1.99), which was the most common; 
the use of anti-depressants such as bupropion (12 RCTs, OR 1.56, 95% CI, 1.10-2.21, P = 
0.01) and varenicline (4 RCTs, OR 2.96, 95% CI, 2.12-4.12, P = <0.0001); and the 
combination of NRTs and anti-depressants as co-therapies. The authors identified that 
effective mechanisms to improve smoking cessation are vital.  Smoking is the number 
one preventable cause of death in the world.  Cessation of smoking can also further 
reduce airway complication, lower rates of cerebrovascular disease, and coronary artery 
disease.         
Wu et al. concluded that even though the exact mechanism of each intervention is 
different, using only one method for smoking cessation was not effective.  At the one 
year mark smoking prevalence remained high among the experimental groups for all 3 
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interventions.  The authors suggested combination therapy should be individualized to the 
patient’s symptoms.   
A RCT by Hennrikus et al. (2010) studied the effectiveness of a smoking 
cessation program for peripheral vascular disease (PVD) patients.  The authors’ 
hypothesis was that patients with PVD need a focused intensive intervention, due to the 
serious nature of atherosclerotic disease which has the potential of causing major 
disability.  Smoking is a completely modifiable risk factor affecting PVD.  Outpatients 
with lower extremity PVD were identified from medical records as smokers.  Subjects 
were randomly assigned to either an intensive PVD specific counseling intervention or a 
minimal smoking cessation intervention.  The results suggested that subjects assigned to 
the intensive counseling were more likely to be confirmed abstinent from smoking at six 
month follow-up, with 21.3% in the intervention group vs. 6.8% in the minimal 
counseling group.   
Tahiri et al. (2012) conducted a meta-analysis of RCTs of alternative smoking 
cessation therapies. The three alternatives to pharmacotherapies for smoking cessation 
were acupuncture, hypnotherapy, and aversive smoking.  They systematically searched 
the Cochrane Library, EMBASE, Medline, and PsyclNFO through December 2010.  
Only RCTs that reported cessation point outcome between six to 12 months were used.  
Of the articles searched 14 trials were selected:  six investigated acupuncture, four 
investigated hypnotherapy and four investigated aversive smoking.  A separate meta-
analysis was carried out for each alternative therapy. 
In respect to acupuncture, smoking cessation substantially increased (point 
estimate OR, 3.53).  Hypnotherapy was found to be efficacious at promoting smoking 
cessation (point estimate OR 4.55); however, confidence intervals were wide thus 
limiting a strong conclusion.  Aversive smoking substantially increased smoking 
abstinence compared with control (point estimate OR 4.26).  All results were at the one 
year mark. 
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Tahiri et al. concluded that up to 30% of individuals trying to quit smoking seek 
alternative interventions for fear of pharmacotherapies.  The authors suggested that more 
healthcare providers offer these alternative smoking cessation aides to their patients and 
those researchers continue studying these methods for their efficacy. 
Attitudes and Beliefs About Smoking Cessation 
 A dearth of literature exists on the attitudes and beliefs of patients and smoking 
cessation.  Ronayne, O’Connor, and Scobie (1989) conducted a descriptive study which 
examined the differences in beliefs and social influences between patients who decided to 
quit smoking or decided to continue to smoke, following the diagnosis of PVD.  Ronayne 
et al. sought to determine why some individuals, after learning of their PVD illness stop 
smoking, while the majority of individuals continue to smoke despite counseling from 
their healthcare provider. The authors investigated individuals with PVD, since the 
progression of the disease can lead to devastating disability or loss of limb. The beliefs 
influencing patients’ decision to quit, reduce number of cigarettes, or to continue to 
smoke is not fully understood.  The researchers conducted a study to determine the 
influence of beliefs and social influences on patients’ decisions to quit or continue to 
smoking using Ajzen and Fishbein’s Theory of Reasoned Action.  A consecutive quota 
sample of 20 patients who had quit smoking and 22 smokers who continued smoking 
participated in the study.  Data for this study were collected using a 
qualitative/quantitative methodology, utilizing the specific guidelines as described by 
Ajzen and Fishbein (1980).  Each group was asked to complete a quantitative open ended 
survey questions using a 7-point Likert scale regarding questions about smoking or non-
smoking.  The six quantitative beliefs about smoking outcomes listed in the survey were 
reduced risk of amputation, increased tension, weight gain, walk better, better circulation, 
and avoid leg surgery.   
 A qualitative analysis was performed looking for themes among the smokers and 
non-smokers.  The three themes discussed were breathing better, walking better and the 
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likelihood of amputation.  Patients from both groups reported quitting smoking was more 
beneficial for their respiratory symptoms over their circulation symptoms.  Patients 
reported “breathing better” and “coughing less”.  Patients were asked to indicate the 
likelihood of occurrence for a number of outcomes resulting from smokers to non-
smokers.   Each outcome was rated on a 7-point Likert scale.  Differences between 
smokers (n=22) and non-smokers (n=20) were significant on the outcomes of increased 
tension (non-smokers -0.79, smokers 2.9, P = 0.003*), weight gain (non-smokers 1.1, 
smokers 3.4, P= 0.01*), and walking better (non-smokers 4.3, smokers 2.6, P=0.035*).  
Non-smokers reported being more confident that smoking cessation would substantially 
increase the likelihood of walking better and reduce feelings of tension.  The non-
smokers also reported not being fearful of weight gain since they had less difficulty 
walking.   
The likelihood of amputation was elicited using probability scales of 0-100%.  
Patients in both groups were asked the probability of amputation associated with quitting 
or continuing smoking.  Attitudes towards smoking were divided into three categories: no 
risk (non-smokers 5.5%, smokers 43%), acceptable risk (non-smokers 0%, smokers 
10%); and unacceptable risk (non-smokers 94%, smokers 47%).  Patients who quit 
smoking reported the risk of amputation to be more substantially reduced than those who 
did not quit smoking.  Attitudes toward the risk of amputation revealed 94% (n=18) of 
those who quit smoking perceived the risk of amputation as unacceptable while 53% 
(n=11) of those who did not quit smoking perceived the risk to be negligible or 
acceptable.  The remaining 47% (n=13) of smokers perceived the risk of amputation to be 
acceptable but were powerless to do anything about it.   There were no statistically 
significant differences between smokers and non-smokers in demographic characteristics, 
clinical variables, and perceived social influences.  Significant differences were found 
between groups in beliefs about and attitudes towards the risk of continued smoking.  Of 
interest is the finding that respiratory issues (non-smokers n=20; smokers, n=10) 
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provided more benefit over circulatory issues (non-smokers n=8; smokers, n=4).  Both 
groups reported that their physician, family and friends encouraged them to quit smoking.  
The results of this study support the need to investigate more fully the factors which 
influence patients’ decisions to quit or to continue to smoke.  
Parry, Thomson, & Fowkes (2001) examined the reasons for continuing to smoke 
from a sample of long-term older smokers who have PVD.  The participants were a 
subset of a larger qualitative study of Life Course Influences on Patterns of Persistent 
Smoking.  Semi-structured interviews were conducted.  These studies enlisted the use of 
“life grids” which charted changes in levels and patterns of smoking against events and 
circumstance in the smokers’ lives.  It also examined the beliefs about why they smoke 
their current smoking behavior and their future intention.   Some smokers justified 
continued smoking to the addictive properties of cigarettes, therefore, this addiction 
served to legitimize their claims of entitlement to the unhealthy habit.  It appeared 
smokers feared the symptoms of nicotine deprivation, making quitting a difficult task.       
The respondents (n=70) were recruited from the Edinburgh Artery Study.  The  
respondents were 22 current smokers and 48 ex-smokers, ages ranging from 65 to 84 
years old, with at least 10 years smoking history, who averaged at least 10 cigarettes a 
week with presence of arterial disease.  The study used quantitative interviews which 
incorporated life grids.  A life grid is a system the authors utilized to collect patterns and 
levels of cigarette use across their life course.  The grid examined smoking behaviors, 
including patterns of daily cigarette consumption, subjective dependence, and beliefs 
about social influence on smoking, the perceived relationship of life events/experiences 
and smoking, perceived influences, and advice from medical practitioner on smoking 
behavior.    
The findings revealed older smokers with arterial disease defined their 
relationship to smoking in either a dependent or functional terms.  Dependent smokers 
did not believe they were dependent on smoking while non-dependent smokers did not 
17 
	
think of themselves as a smoker.  Older smokers, despite high levels of cigarette 
consumption, made no correlation to addiction to justify their smoking.  Others stated 
they “could quit at any time”.  These smokers perceived cigarettes as a positive resource; 
the perceived beliefs outweighed the benefits of quitting.  Although Parry et al. examined 
the reasons to smoke their findings demonstrated their perceived beliefs outweigh 
benefits of quitting.  Therefore, it is critical to identify patients’ beliefs, normative 
beliefs, and control beliefs as a determinant of their behavior.    
 Clarke & Aish (2002) conducted a descriptive cross-sectional aspect of a study of 
smokers with PVD who chose to participate in a smoking intervention compared with a 
group of smokers who declined to participate in the intervention.  This study was based 
on the integration of the following three theoretical models:  Ajzen and Fishbein’s 
Theory of Reasoned Action, Kenney’s Expected Utility Decision Theory, and Prochaska 
and DiClemete’s Transtheoretical Model of Change.  These theoretical models were used 
to describe the influence of this smoking cessation program on the beliefs and attitudes 
about smoking.  Upon review of the extensive empirical studies related to smoking 
cessation, the authors noted patterns between smoking cessation and smokers’ beliefs and 
attitudes, optimistic bias, and social influences.  Certain individuals are more likely to 
quit smoking if  they: believe that such actions will reduce the likelihood of disease 
progression, surgery, or amputation; perceive that smoking cessation is considered 
worthwhile by others they wish to please; consider living as non-smokers.  
A nonprobability convenience sample was obtained from recruited participants 
who were smokers with vascular disease, at least 18 years or older, smoked at least one 
cigarette a day, were diagnosed with vascular disease, including PAD, carotid disease, 
and abdominal aortic aneurysms were where able to communicate in English.  A smoking 
beliefs questionnaire designed to capture subjects’ characteristics, stage of smoking 
change, subjective norm, attitudes, and expected utility was used.  The participants 
completed the survey before the smoking cessation intervention and 13 weeks after the 
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intervention.  Smokers who decided not to participate in the intervention also completed a 
questionnaire for comparison.  The intervention consisted of a physician guide with 
instructions about how to ask, advise, and assist patients to quit smoking, along with 
periodic assessment and personalized feedback reports.   
The intervention group was identified as group 1 and included who participated in 
the smoking cessation program; group 2 included those who did not participate in the 
smoking cessation program but were willing to complete questionnaires.  The results 
revealed statistically significant differences between group 1 and group 2.  Subjects in 
group 1 (n=34, 79%) were more often diagnosed with PAD than those in group 2 (n=25, 
58%).  Eighty-six percent (n=37) of group 1 subjects smoked 11 or more cigarettes a day, 
whereas only 67% (n=28) of group 2 smoked 11 or more cigarettes per day.  The amount 
smoked by the subjects in group 1 decreased significantly during the 13 week period 
from 86% (n=37) who smoked 11 or more cigarettes per day to only 58% (n=25).  
Eighty-one percent (n= 35) of group 1 believed that it was highly likely that they would 
develop more serious circulatory health problems, and only 50% (n=35) of group 2 
believed this.  Participants who did not enroll in the intervention were less educated 
(84%, n=36 graduated high school in group 1 and 49%, n=21 finished in group 2), less 
often diagnosed with PVD, were more in the precontemplating stage of change regarding 
smoking cessation and cared more about what the physician and family thought they 
should do.  They perceived themselves to be at less risk for developing more severe 
circulatory problems if they did not stop smoking.  This group of patients is on the 
disastrous pathway as described earlier. 
When different populations were compared, there was no significant difference 
between primary care, in-patients, or pregnant women in the likelihood of quitting.  What 
was significant were the providers who delivered the smoking cessation material.  
Physician were significantly more effective in promoting cessation (Beta=4.13, P= 
0.005).  Nurses were less effective (Beta=   -0.86, P=0.45).  There were no significant 
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differences between dentists and team providers (Beta=0.73, P=0.69).  The findings 
support the promise of smoking cessation counseling by all healthcare providers and that 
additional longer-term trials of provider-based cessation approached are warranted.   
A more recent study by Rajaee et al. (2014) examined whether the type of 
revascularization for peripheral arterial disease (PAD), percutaneous vs open procedure, 
was associated with smoking reduction.  Among patients with PAD, smokers have a 
higher incidence of life- and limb-threatening complications, including lower extremity 
ischemic rest pain.  Smokers are 2.3 times more likely to be symptomatic from PAD and 
have a higher incidence of lower extremity ischemic pain.   
This study compared rates of smoking reduction after medical, percutaneous, and 
open intervention among patients with PAD and evaluated patients’ perceptions of 
smoking.  The study consisted of two parts, a retrospective chart review and a review of 
patients answered surveys.  In the chart review, potential study participants were 
identified through a search of International Classification of Diseases, Ninth Division 
(ICD-9) codes for all patients seen by 1 of 3 vascular surgeons at an academic center.  All 
patients undergoing evaluation and management for lower extremity PAD were included.  
Exclusion criteria included patients younger than 18 years old, absence of follow-up 
visits after initial consultation, and presence of acute limb-threatening ischemia.   
The survey format allowed assessment of the patient perceptions of the impact 
that smoking had on the development of the disease.  Patients were asked to rate several 
factors (diabetes, smoking, diet, sex, ethnicity, age, alcohol use, hypertension, and family 
history) based on the extent they believed the factor played a role in the development of 
disease.  The surveys used a 5-point Likert scale to ask the participants whether their 
interventions were life-changing events and whether they had changed their diets, 
smoking habits, or attention to blood pressure as a result.   
Of the 142 surveys submitted, 67 patients were former smokers, 20 were never 
smokers, and 55 were active smokers at the time of the intervention.  Of the 67 former 
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smokers, 25% (n=17) had undergone open interventions, 45% (n=30) had undergone 
percutaneous interventions, and 30% (n=20) had undergone medical management.  None 
of the former smokers restarted smoking after their interventions.  Of the 55 active 
smokers, 33% (n=18) had undergone open intervention, 44% (n=24) had undergone 
percutaneous interventions, and 22% (n=12) had undergone medical management.   
Rajaee et al. (2014) concluded that 55 patients were active smokers at the time of 
their intervention.  Sixty seven percent (n=8) in the medical management group, 50% 
(n=12) in the percutaneous group, and 83% (n=15) in the open intervention group 
reduced their smoking by 50% after intervention.  The authors reported that after 
controlling for several cofounders, open revascularization was independently associated 
with smoking reduction when compared to percutaneous intervention by 50%. Surveys 
also revealed that 94% (n= 23) of the participants believed that smoking was a significant 
contributor to their PAD.  Patients with PAD who underwent open vascularization were 
more likely to reduce smoking by 50% compared to (95% CI, 1.18, 76.67; P= 0.043) 
those who undergo percutaneous revascularization and that the perioperative period 
provide an opportunity to improve rates of smoking reduction (Rajaee et al., 2014).  
Of the 55 participates included in the study, eighty three percent (n=45) patients 
attempted smoking cessation (Rajaee et al., 2014).  No established program for cessation 
existed at this institution, but the vascular surgeons routinely with each office visit offer 
smoking cessation counseling and discuss the benefits of quitting.  For patients that are 
amenable to pharmacologic aids, either the vascular surgeons prescribed Chantix, 
nicotine patches, or nicotine gum.  Or they referred the patients to their primary care 
provider for their prescriptions.  A total of 37% (n=20) received a prescription for 
pharmacological aids, along with 37% (n=20) incorporated nicotine replacement therapy 
as well.  Also 18.5% (n=10) patients were referred for formal smoking cessation 
counseling, while 14.8% (n=8) attempted hypnosis as a method to help them quit 
smoking.   
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In summary, a comprehensive review of literature examined several areas for 
APRN and health care provider intervention:  epidemiology of smoking; hazards of 
smoking; nicotine addiction; current strategies in smoking cessation; and more specific to 
this study, peoples’ attitudes and beliefs about smoking cessation.  There is a vast amount 
of literature regarding interventions pertaining to smoking cessation, however only four 
articles in the last 20 years examined patients’ attitudes and beliefs towards smoking.  
The purpose of this study is to identify the attitudes and beliefs of patients with PVD.  If 
attitudes and beliefs towards smoking can be identified, pertinent interventions may be 
developed in an effort to enhance smoking cessation efforts and in the long-term 
potentially reduce vascular interventions associated with smoking. 
The next section describes the theoretical framework used to guide this study. 
 
 
 
 
 
Theoretical Framework 
The Theory of Reasoned Action (TRA) was first introduced by Ajzen and 
Fishbein in 1980.  This model was developed for the prediction of behavioral intention, 
as a determinant of attitude and subjective norms.  Ajzen and Fishbein posit that 
behavioral intention, as immediate antecedents to behavior are salient beliefs about the 
likelihood that preforming a particular behavior will lead to a specific outcome.  (Madden 
& Ellen, 1992) Behavioral intentions are divided into two salient beliefs:  behavioral and 
normative.  Ajzen stated the subsequent separation of behavioral intention from the 
behavior allows for explanation of limiting factors on attitudinal influence and subjective 
norm.   In 1991, Ajzen published more articles extensively on TRA and then went on to 
extend the theory and developed the Theory of Planned Behavior (TPB)  (Anderson & 
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Lavallee, 2008) The TPB extends the TRA with the addition of perceived behavioral 
beliefs and perceived power to predict deliberate behavior and how that behavior can be 
changed in individuals.  According to TPB, human action is guided by three kinds of 
salient beliefs: 
Behavioral beliefs:  beliefs about the likely consequences of the behavior 
Normative beliefs:  beliefs about the normative expectations of others  
Control beliefs:  beliefs about the presence of factors that may facilitate or impede 
performance of the behavior.  (Anderson & Lavallee, 2008) 
 
 Ajzen’s considerations are crucial in circumstances, projects, and programs that 
work with changing behaviors of people.  In each perspective aggregate, behavioral 
beliefs produce a favorable or unfavorable attitude towards the specific behavior.  
Normative beliefs result in perceived social pressure and subjective norm.  Control 
beliefs are the third antecedent of behavioral intention defined as the individual’s belief 
concerning perception control and person’s actual control over the behavior. 
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The TRA and TPB are two of the most predictive persuasion theories in the 
literature.  (Anderson & Lavallee, 2008)  These two theories have been applied to studies 
of the relationship among beliefs, attitudes, behavioral intentions, and behaviors in 
various arenas ranging from advertising to healthcare.   Ajzen states that salient beliefs, 
normative beliefs, and control beliefs are components that lead to the formation of 
behavioral intent.  In concert with one another, these beliefs are presumed to not only 
affect behavior directly, but also affect it indirectly through behavioral intention.  Ajzen 
stated “If the individual has limited control of a given behavior, investigators should not 
only study the intention, but also the perceived control the individual has over the 
behavior” (Godin, Valois, Lepage, & Deshamais, 1992, page 3).  He further emphasized 
that perceived control can influence intention, as well as attitudes and subjective norm, it 
can predict behavior directly, in parallel with potential influence of intention, especially 
in situations where behavior is not under the control of the individual (Godin, Valois, 
Lepage, & Desharnais, 1992). 
Next, the methods in the study will be presented. 
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Method 
Purpose 
The purpose of this project was to identify the behavioral, normative and control 
beliefs of patients with PVD towards smoking. 
Research question 
 What are the behavioral, normative, and control beliefs of patients with PVD 
towards smoking? 
Design 
A non-experimental, descriptive design was utilized.   
Sample and Site 
A convenience sample was drawn from 50 patients at a vascular surgeon’s private 
office associated with a major trauma center.  Inclusion criteria were: age 65 or greater; 
must be a current smoker; who smoke at least one pack per day and have smoked for the 
past 15 years; had at least one vascular intervention, either bypass or stent.  Exclusion 
criteria included:  age 65 or less; do not currently smoke; have quit smoking for more 
than one year; never had a vascular intervention. 
Procedures 
  Institutional Review Board (IRB) approvals were obtained from Rhode Island 
Hospital and Rhode Island College. Data collection began after IRB approval 
notification.  The research investigator selected to focus the project around a vascular 
surgeon with high volume of patients with recurrent vascular disease.  The research 
investigator was present in the waiting room of the vascular surgeon’s office on the two 
days per week that consultations were provided.  Upon arrival to office, all patients were 
routinely asked by the office staff to complete a CMS Medicare Payment Reconciliation 
System (PRS) Form for which addresses 4 questions:  1). Smoking status; 2). Pain scale; 
3). Medications; 4). Surgical history.  The potential participant's chart was pre-screened 
by the staff in the form of Medicare Inquiry of Smoking status. Either the patient's nurse 
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or the doctor asked the patient if the NP student could speak to them about participating 
in a smoking survey study.  The patient was approached by the physician in a private 
room and asked if he/she might be interested in participating in this study. The patient 
was given ample time to consider participation and a chance to ask any questions. If they 
agreed, detailed instructions regarding the purpose of the survey, and how to complete 
the survey, were provided.  Potential participants were then provided the consent to 
review and questions were answered.  Upon signed consent, participants were asked to 
complete the questionnaire before leaving the vascular surgeon’s office.  Although IRB 
approval has been obtained, all information collected was de-identified to ensure patient 
confidentiality.   
Measurement/Questionnaire Development 
The survey used collected the following demographic information:  age; gender; 
years smoked; number of previous vascular surgeries/procedures; date of last 
procedure/surgery; level of education; and employment status.  The purpose of this 
project was to identify the behavioral, normative and control beliefs of patients with PVD 
towards smoking. 
In concert with this aim, the Theory of Planned Behavior (TPB) provides specific 
guidelines for researchers to adapt and develop their questionnaire to collect specific 
data.  The Ajzen and Fishbein questionnaire guidelines were used and modified to 
capture the constructs of the TPB related to smoking.  Using this guide each question was 
adapted to represent one of the three constructs as they related to smoking and PVD.  
Each question looked at behavioral, normative, or control beliefs as they related to each 
patients’ thoughts toward smoking and how they felt smoking affected or didn’t affect 
their PVD.  The term questionnaire, which Ajzen utilizes, and survey will be used 
interchangeably.   
A questionnaire was developed to obtain the required data utilizing the TPB.  The 
questions developed for the questionnaire followed the TPB framework, appraising 
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behavioral beliefs, normative beliefs (significant other influence) and control beliefs.   
The guidelines to develop the questionnaire define the behavior of interest in terms of its 
Target, Action, Context and Time. To secure reliable, internally consistent measures, it is 
necessary to select appropriate items in the formative stages of the investigation. (Ajzen, 
2006)  Therefore, selected items for the questionnaire were formulated to obtain a direct 
measure of behavioral beliefs, normative beliefs or perceived control beliefs toward the 
smoking behavior. The literature observations and clinical experience with patients with 
PVD regarding smoking were utilized to develop the items in the questionnaire.  Specific 
items were developed to obtain the data required for each of the three belief sections to 
provide a complete summary of the patients thought process regarding smoking behavior. 
  The questionnaire was limited to two pages.  Questions were closed-ended 
utilizing a Likert type rating scale ranging from 1-7 with bipolar adjectives that were 
anchored by ‘not at all’ (-)  to ‘very much’ (+).  Participant responses for each question 
were ranked on a Likert scale ranging from 1 to 7 with end points of “not at all” (-) to 
“very much” (+).  The rankings were analyzed by the following scale where end point 
“not at all” utilized “extremely –“, “quite-“, and “slightly-“.  The neutral or non-
applicable was represented by “neither”.  The end point of “very much” utilized “quite+”, 
“slightly +”, and “extremely+”.   Ordinal level data was collected.  The font was at least 
size 14 to accommodate older participants or those with difficulties with smaller fonts.  
The questionnaire was developed at a sixth grade reading level.   
The questionnaire was evaluated for its content validity by the two vascular 
surgeons.  The physicians provided feedback on additional questions that should be 
included in the questionnaire.  As a result, the following three questions were developed: 
Question  3.)  Do you believe that smoking only causes cancer? Question 8.)  Do you 
believe that your problem with blocked blood vessels is caused by smoking; and 
Question 9.)  Do you believe that secondhand smoke can decrease blood flow in your 
legs?  Each of the vascular surgeons were interested in their patients’ thoughts on these 
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three topics in an effort to obtain insight to some basic knowledge correlating nicotine 
and atherosclerosis. 
Data Analysis 
  Demographics and belief questionnaire data were collected and managed using 
REDCap (Research Electronic Data Capture) tool hosted by Lifespan.  REDcap is a 
secure, web-based application to support data capture for research studies, providing 1) 
an intuitive interface for validated data entry; 2) audit trails for tracking data 
manipulation and export procedures; 3) automated export procedures for seamless data 
downloads to common statistical package; and 4) procedures for importing data from 
external sources.  Data analysis consisted of descriptive statistics of the demographic 
data:  percents and means of the 20 item questionnaire were examined and exported to 
Microsoft Excel for further data analysis.   
Next, the study results will be presented. 
 
Results 
Demographics 
Table 1 on the next page illustrates the demographic data that were collected.  The 
majority of the participants (N=50) were male (n=31; 67%) while females represented 
37% (n=19) of the sample.  Age ranged from 25-85+ years; the age group 65-74 years 
represented 36% (n=18) of all participants while 55-64 years 30% (n=15) represented the 
second largest age category.  Most participants had a high school education (n=21; 42%); 
two years of college/trade school (n=17; 34%) ranked second.  Most participants did not 
work (n=30; 60%), while the remainder of the sample worked (n=20; 40%).  Smoking 
history ranged 11 years to 51+ years.  Half of participants smoked for 41 to 51+ years 
(n=24) or 50%; 26% (n=13) smoked for 51+ years or more, with 16% (n=8) in the 41-45 
years range. 
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Table 2 provides an overview of the individual questions and the number of 
participants that responded positively, negatively, or not at all (where n= + are the 
participant responses that were read on the positive end of the scale while n= - are 
participant responses that were read on the negative end of the scale).  
Table	2	
Participant	Responses	Positive	(+)	Negative	(-)	Neither	Rating	
	
Behavioral,	Normative	and	Control	Beliefs 
 
Mean n=	+ n=	- Neither 
Behavioral     
Question 1     How much do you enjoy smoking?   
Question 2     Does smoking help you to relax?  
Question 3     Do you believe that smoking only causes cancer? 
Question 4     Do you believe you smoke because you are stressed? 
Question 5     Do you believe you smoke because you are bored? 
Question 6     Do you believe that smoking helps to control  your 
                      weight? 
Question 7     Do you believe that you are addicted to smoking? 
Question 8     Do you believe that your problem with     
                       blocked blood vessels are caused by smoking? 
Question 9     Do you believe second hand smoke can 
                       decrease blood flow in your legs?  
4.88 
5.48 
2.48 
4.62 
4.08 
2.76 
5.94 
 
4.76 
3.96 
29 
39 
12 
30 
26 
13 
43 
 
31 
22 
13 
9 
36 
15 
20 
31 
6 
 
13 
18 
8 
2 
2 
5 
4 
6 
1 
 
6 
10 
Normative     
Question 10   Does your spouse/significant other approve of    
                       your smoking? 
Question 11   Do your children or those who live with you 
                       approve of your smoking?  
Question 12   Do your peers influence/support your smoking? 
Question 13  Has your healthcare provider talked about  
                      quitting smoking? 
Question 14   How often are you around others who smoke?  
 
2.86 
 
2.42 
2.40 
 
6.36 
4.52 
 
7 
 
4 
5 
 
4 
25 
 
28 
 
31 
35 
 
44 
  20 
 
15 
 
15 
10 
 
2 
5 
Control     
Question 15   Have you ever tried to quit smoking before? 
Question 16   Do you believe it would be easy not to smoke next    
                       month? 
Question 17   How much control do you think you have over 
                       whether you smoke?  
Question 18   Do you believe you can quit smoking without help? 
Question 19   Do you believe you can quit smoking with the  
                       help of a patch or medication? 
Question 20   Are you afraid of nicotine withdrawal symptoms  
                       if you stop  smoking? 
6.38 
3.46 
 
4.22 
3.24 
 
3.50 
 
2.96 
47 
18 
 
22 
17 
 
19 
 
16 
3 
27 
 
21 
32 
 
25 
 
32 
0 
5 
 
7 
1 
 
6 
 
2 
 
The major findings of the Behavioral beliefs suggested that the majority of participants 
enjoyed smoking (n=29) while (n=8) were indecisive.  Smoking is used to help 
participants to relax (n= 39) and most participants (n=43) believed they are addicted to 
smoking.  The effects of second hand smoke were neutral while (n=10) were again 
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indecisive.  The major findings of the Normative beliefs were family, significant other, 
children and peers do not approve of the habit of smoking while (n=15) had no opinion.  
The major findings of the Control beliefs were most participants (n=47) tried to stop 
smoking in the past and feared  the withdrawal symptoms (n=32).     
 
Participants’ Behavioral Beliefs Reponses 
 Table 3 provides an overview of the mean scores for each behavioral belief as 
listed in Questions 1-9 of the survey.  Participant responses for each question were 
ranked on a Likert scale ranging from 1 to 7 with end points of “not at all” (-) to “very 
much” (+).  The rankings were analyzed by the following scale where end point “not at 
all” utilized “extremely –“, “quite-“, and “slightly-“.  The neutral or non-applicable was 
represented by “neither”.  The end point of “very much” utilized “quite+”, “slightly +”, 
and “extremely+”.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 
Participant Responses to Behavioral Beliefs 
             
Behavioral Beliefs          Mean    
             
 
1.  How much do you enjoy smoking?      4.88 
2.  Does smoking help you to relax?       5.48 
3.  Do you believe that smoking only causes cancer?    2.48 
4.  Do you believe you smoke because you are stressed?    4.62 
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5.  Do you believe you smoke because you are bored?    4.08 
6.  Do you believe that smoking helps to control your weight?   2.76 
7.  Do you believe that you are addicted to smoking?    5.94 
8.  Do you believe that your problem with blocked blood vessels is caused by  
     smoking?          4.76 
9.  Do you believe second hand smoke can decrease blood flow in your legs? 3.96   
 
       
The mean score  for behavioral beliefs ranged between 4.08 and 5.94, with the exception 
of question 3 (“Only smoking causes cancer”), question 6 (“Smoking helps to control 
your weight”), and question 9  (“Secondhand smoke can decrease blood flow in your 
legs”).  The mean of 2.48 for question 3 indicated participants’ belief that other diseases 
cause cancer, as well as smoking.  The mean for question 6 was 2.76, which indicated 
smoking does not control weight.   The mean of 3.96 for question 6, secondhand smoke 
can decrease blood flow to your legs, indicated a lack of knowledge concerning the 
effects of second hand smoke.   
 
Participant Normative Beliefs Reponses 
 Table 4 provides an overview of the mean scores for each normative belief as 
listed in questions 10 through 14.  Participant responses for each question were ranked on 
a Likert scale ranging from 1 to 7 with end points of “not at all” (-) to “very much” (+).  
The rankings were analyzed by the following scale where end point “not at all” utilized 
“extremely –“, “quite-“, and “slightly-“.  The neutral or non-applicable was represented 
by “neither”.  The end point of “very much” utilized “quite+”, “slightly +”, and 
“extremely+”.    
 
Table 4 
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Participant Responses to Normative Beliefs 
             
Normative Beliefs          Mean    
             
 
10.  Does your spouse/significant other approve of your smoking?   2.86 
11.  Do your children or those who live with you approve of your smoking? 2.42 
12.  Do your peers influence/support your smoking?     2.40 
13.  Has your healthcare provider talked about quitting smoking?   6.36 
14.  How often are you around others who smoke?  	 	 	 4.52	
 
The mean scores ranged from 2.40-2.86.  Spouse, significant other, children, those lived 
with, and peers all strongly opposed smoking behavior. Most notably, the highest mean 
score 6.36, question 4, which reflected the importance of the healthcare providers’ 
recommendations on smoking cessation.  Also, question 5, with a mean of 4.52 suggested 
participants with PVD are frequently around others who smoke.   
Participant Control Beliefs Reponses 
 Table 5 provides an overview of the mean scores for each control belief as listed 
in questions 15 to 20.  Participant responses for each question were ranked on a Likert 
scale ranging from 1 to 7 with end points of “not at all” (-) to “very much” (+).  The 
rankings were analyzed by the following scale where end point “not at all” utilized 
“extremely –“, “quite-“, and “slightly-“.  The neutral or non-applicable was represented 
by “neither”.  The end point of “very much” utilized “quite+”, “slightly +”, and 
“extremely+”.    
 
Table 5 
Participant Responses to Control Beliefs 
             
Control Beliefs                     Mean    
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15.  Have you ever tried to quit smoking before?      6.38 
16.  Do you believe it would be easy not to smoke next month?    3.46 
17.  How much control do you think you have over whether you smoke?    4.22  
18.  Do you believe you can quit smoking without help?                           3.24 
19.  Do you believe you can quit smoking with the help of a patch or medication?   3.50 
20.  Are you afraid of nicotine withdrawal symptoms if you stop smoking?   2.96  
 
The mean scores ranged between 3.24-4.22 reflecting the belief that smoking cessation 
would be a difficult task.  Participants’ perception of the control they have to stop 
smoking varied from both endpoints with ‘extremely’ no control (n=21) to ‘extremely’ 
have control (n=22) equally.  In addition, most subjects indicated they needed help to quit 
smoking and required a patch or medication.  Most patients, as reflected by the highest 
mean score of 6.38, attempted to quit smoking in the past and failed.  The lowest mean 
score of 2.96 suggested patients with PVD did not want to experience smoking 
withdrawal symptoms.     
  In summary, the principle findings of this study suggest patients with PVD 
smoke because they find it pleasurable and want to quit but fear the adverse effects.  
Family and friends are important regarding this decision but fail to make a difference. 
Therefore, this data provides a compelling basis for future educational endeavors.   
              Next,  summary and conclusions are discussed. 
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Summary and Conclusions 
This research study originated from the researcher’s many years of experience 
caring for patients with PVD.  These patients often endure numerous readmissions to the 
hospital for revascularization interventions and despite that continue to smoke.  It is 
imperative to explore the reason why such  patients continue to smoke.  One of the most 
compelling relevant studies in the literature was conducted by Ronayne, O’Connor, and 
Scobie (1989).  This descriptive study examined the differences in beliefs and social 
influences between patients who decided to quit smoking or decided to continue to 
smoke, following the diagnosis of PVD.  Ronayne et al. sought to determine why some 
individuals, after learning of their PVD illness, stop smoking while the majority of 
individuals continue to smoke despite counseling from their healthcare provider.  The 
following six beliefs about smoking were elicited: increased tension; weight gain; walk 
better; better circulation; avoid leg surgery; and reduced risk of amputation,.  However, 
an important finding was  that patients believed their improved respiratory status was 
more beneficial than their improved peripheral vascular status.   It was precisely this 
insight into patients’ thought process that has guided the efforts of  healthcare providers 
to establish smoking cessation regimens for individuals with PVD who continue to 
smoke.  The purpose of this project was to identify the behavioral, normative and control 
beliefs of patients with PVD towards smoking. 
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 The TPB (Ajzen, 1985) was applied to smoking behavior to explore the three 
belief determinants of behavior.  Behavioral beliefs produce a favorable or unfavorable 
attitude toward the smoking behavior; normative beliefs reflect the individual’s beliefs 
regarding significant others’ approval or disapproval of their smoking and result in 
perceived social pressure or subjective norm. Finally, control beliefs give rise to 
perceived behavioral control as a determinant of behavior.  The three constructs of the 
TPB were incorporated into the survey developed by this researcher as specific questions, 
guided by the author’s instructions.   
            A convenience sample was drawn from 50 participants at a vascular surgeon’s 
private office associated with a major trauma center. The study participants consisted of 
both males and females.   Of the 50 participants,  the majority were male,  age 65-75, 
unemployed, with either a high school or two years college/trade school education, who 
smoked for 40+ years, experienced one to three procedures/surgeries in the past, and 
where the last procedure occurred within one year.  The participants completed a 
questionnaire that asked them to rate 20 questions about smoking on a Likert scale .   In 
general, the behavioral belief questions suggested that patients with PVD find smoking 
pleasurable, while others responded negatively to this question and indicated they were 
disgusted with their smoking habits but were nevertheless addicted. Most participants 
responded that smoking helps them to relax.  Similarly, participants also responded that 
they smoked because they were stressed and use smoking  as an aid for stress reduction 
and relaxation.   Participants responded equally that they smoked because they were 
bored or in contrast boredom had nothing to do with the smoking behavior, raising the 
issues of habit and addiction for this belief.  Participants did not believe that only 
smoking causes cancer, which supports the rationale to smoke. This finding infers a 
belief that patients with PVD utilize smoking to support their smoking behavior.  This is 
a defense mechanism to continue this risky behavior.   Denial of the causal connection 
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between smoking and cancer is evident as participants inferred that other diseases also 
cause cancer: Individuals who do not smoke get lung cancer as well.  
Contrary to popular belief that smoking curbs appetite, this idea was not 
supported by the participant responses. Participants in this sample did not smoke to 
control their weight.   Participants  indicated that their blocked blood vessels were caused 
by smoking, however, they continued to smoke and experience harmful, physical effects.  
Participants were not aware that secondhand smoke can be harmful.  Smoking’s harmful 
effects occur via inhaling byproducts of smoke where secondhand smoke is in the 
atmosphere and has harmful effects to those exposed to it. 
The normative belief questions revealed that the spouse or significant other did 
not approve of the participant smoking behavior.  Children and peers as well did not 
approve of the smoking behavior.  The principal  finding was that the healthcare provider 
had discussed smoking cessation with the patient (n=44; 88%).   In light of this social 
pressure, people with documented PVD continued to smoke.  The results of the frequency 
with which participants are around others who smoke did not offer any differences.  
Although the measure of subjective norm suggested disapproval by others of an 
undesirable behavior,  patients continued to smoke. 
The control belief questions suggested that a significant number of participants 
tried to quit smoking in the past (n=47; 94%).  Smoking cessation would not be an easy 
task to perform and perception of control was viewed both positively (n=22; 44%) and 
negatively (n=21, 42%). Assistance may be required by some but most believed they 
could do it without a patch or medications and most participants worried about smoking 
withdrawal symptoms.  Perceived behavioral control beliefs captured the participants’ 
confidence that they are capable of performing the behavior under investigation.   
  This research study had several limitations.  The sample was drawn from one 
private vascular physician’s office where patients voluntarily sought care; therefore, the 
ability to generalize finding to the larger population is limited.  Additionally,  the focus of 
37 
	
this study was on a specific patient population, patients with PVD who smoke.   A 
methods limitation was the development of the belief questionnaire; a qualitative open-
ended survey could have been administered to elicit what patients like and dislike about 
the behavior under study, in this case smoking. Subsequently, the beliefs which emerged 
from this qualitative data are then used to develop the quantitative scales which are then 
evaluated by the same patients.  This would then apply to the other normative and control 
belief sections as well.  Beliefs are not directly observed but must be inferred from 
observable responses to posed questions. 
Next, recommendations and implications for advanced practice nursing will be 
discussed. 
 
 
 
 
 
 
 
 
 
 
 
Recommendations and Implications for Advanced Nursing Practice 
Morbidity related to smoking remains the leading preventative cause of death in 
the United Sates today.  Research has shown that health promotion efforts tailored to the 
population are most effective and the advanced practice nurse (APRN) is in a unique 
position to deliver smoking cessation effectively.  This study identified patients with 
PVD beliefs of smoking and its effect on their disease process, atherosclerosis.  Previous 
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research concluded that individuals with PVD continue to smoke without fear of repeated 
revascularization surgeries or even the threat of limb loss.  Within the theoretical 
framework of the TPB, a patient’s deliberate behavior can attempt to be predicted.  The 
theory posits how attitudes, subjective norms, and control beliefs are in part determinants 
of volitional behavior.  
The	APRN	is	in	a	unique	position	to	develop	programs	or	interventions	that	
optimize	patient	outcomes.			This	research,	combined	with	the	relevant	available	
research,	can	provide	a	beginning	foundation	for	program	development.	When	working	
with	patients,	it	is	recommended	that	providers	initially	elicit	their	beliefs	about	the	
designated	behavior	change.		Identifying	beliefs	can	assist	in	gaining	insight	into	the	
cognitive	foundation	of	why	patients	behave	in	a	particular	manner.		With	this	
knowledge,	the	APRN		can		develop	a	smoking	cessation	program	based	on	patient	
beliefs	and	an	understanding	of	patients’	behavior.		Most	educational	programs	or	
interventions	are	developed	based	upon	what	other	healthcare	professionals	believe	to	
be	important	to	change	behavior.		However,	Ajzen	&	Fishbein		have	demonstrated	in	
their	numerous	studies	that	beliefs	are	determinants	of	behavior.		The	APRN	has	the	
ability	to	effect	change	and	is	situated	to	provide	nurse	education	and	policy	
enhancement	in	the	inpatient	or	community	setting.	It	is	frequently	the	role	of	the	
APRN	to	develop	evidence-based	policies	within	the	healthcare	system.		Therefore,	
specific	nursing	interventions	or	program	development	derived	from	patient	beliefs	may	
be	more	likely	to	result	in	successful	patient	outcomes.	More	globally,	implementing	a	
research	program	of	study	based	on	what	patients	want	to	know	or	find	useful		can	be	
the	premise	from	which	educational	efforts	are	derived. 
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This research revealed several opportunities for practice improvement.  
Examining beliefs of patients with PVD provides a greater understanding of what goes on 
in the thought processes of patients, their unique challenges, and the unaddressed needs 
they face.  Exploring the patients’ belief system provides insight into practice 
improvement regarding smoking cessation.  The APRN is adept at identifying existing 
research and disseminating the findings to improve nursing practice. The role of the 
APRN is to role model evidence-based practice and improve patient outcomes. To 
accomplish this goal, the APRN should recognize their role as a colleague within the 
interdisciplinary practice team and their ability to serve as a team member and leader,   
drawing upon nursing’s unique body of knowledge.  The APRN is well suited to develop 
programs or interventions that encompass a holistic perspective of patient care and 
wellness promotion, both hallmarks of advanced practice nursing.  
Nurse-driven research is needed to further explore why PVD patients continue to 
smoke while risking permanent disability. Further research is also indicated to examine 
the relationship between smoking and the extent of revascularization procedures.   
The APRN is a clinical expert.  Understanding what patients believe and their inner most 
thoughts are what constitutes clinical nursing knowledge. 
 
 
 
 
 
 
 
 
 
 
40 
	
 
 
 
 
 
 
 
 
 
 
 
 
 
References 
Ajzen, I. (1985). From intentions to actions:  A theory of planned behavior. Springer 
 Berlin Heidelberg, 11-39. 
Ajzen, I. (2006). Theory of Planned Behavior Questionnaire. Retrieved from 
www.midss.ie 
Ambrose, MD, FACC, J. H., & Barua, MD, PhD, R. S. (2004). The Pathophysiology of 
Cigarette Smoking and Cardiovascular Disease. Retrieved from 
doi:10.1016/j.jacc.2003.12.047 
Anderson, A. G., & Lavallee, D. (2008). Applying the Theories of Reasoned Action and 
Planned Behavior to Athlete Training Adherence Behavior. Applied Psychology:  
An International Review, 57, 304-312. 
Benowitz, MD, N. L. (2010). Nicotine Addiction.  New England Journal of Medicine, 
362 (24) Retrieved from doi:10.1056.1056/NEJMra0809890 
41 
	
Benowitz, N. L. (2009). Pharmacology of Nicotine:  Addiction, Smoking-Induced 
Disease, and Therapeutics. Annu Rev Pharmacol Toxicol, 57-71. 
http://dx.doi.org/10.1146/annurev.pharmtox.48.113006.094742 
Clarke, HBScN, MScN, RN, K. E. & Aish, BSN, MN, PhD, A. (2002). An exploration of 
health beliefs and attitudes of smokers with vascular disease who participate in or 
decline a smoking cessation program. Journal of Vascular Nursing, 20(3), 97-
105. http://dx.doi.org/10.1067/mvn.2002.127735 
Creager, MD, M. A., Kaufman, MD, J. A., & Conte, MD, M. S. (2012). Acute Limb 
Ischemia. Retrieved from NEJM.org 
Fagerstrom, K. (2002). The Epidemiology of Smoking. Drugs, 62, 1-9. 
http://dx.doi.org/10.0012-6667/02/0002-0001/ 
Godin, G., Valois, P., Lepage, L., & Desharnais, R. (1992). Predictors of smoking 
behaviour:  an application of Ajzen’s theory of planned behaviour. British Journal 
of Addiction, 87(3), 1335-1343. Retrieved from www.reasearchgate.net 
Gorin, S. S., & Heck, J. E. (2004, December 2004). Meta-Analysis of the Efficacy of 
Tobacco Counseling by Health Care Providers. Cancer Epidemiology, 
Biomarkers & Prevention, 12(2012-2022), 2012-2022. Retrieved from 
cebp.aacrjournals.org 
Hatsukami, PhD, D. K., Stead, MSc, L. F., & Kupta, PhD, P. C. (2008, June 14, 2008). 
Tobacco Addiction. The Lancet, 371, 2027-2038. Retrieved from 
www.thelancet.com 
Hennrikus, PhD, D., Joseph, MD, MPH, A. M., Lando, PhD, H. A., Duval, PhD, S., 
Ukestad, MS, L., Kodl, PhD, M., & Hirsch, MD, A. T. (2010, July 6, 2010). 
Effectiveness of a Smoking Cessation Program for Peripheral Artery Disease 
Patients. Journal of the American College of Cardiology, 56(25), 2105-2112. 
http://dx.doi.org/10.1016/j.jacc.2010.07.031 
42 
	
Hughson, W. G., Mann, J. I., & Garrod, A. (1978, May 27, 1978). Intermittent 
claudication:  prevalence and risk factors. BMJ, 1, 1379-1381. Retrieved from 
www.ncbi.nlm.nih.gov/ 
Madden, T. J., & Ellen, P. S. (1992, February 1992). A Comparison of the Theory of 
Planned Behavior and the Theory of Reasoned Action. PSPB, 18(1), 3-9. 
http://dx.doi.org/10.1177/0146167292181001 
Montano, D. E., & Kasprzyk (2008). Theory of reason action, theory of panned behavior, 
and the integrated behavioral model. In K. Glanz, B. K. Rimer, & K. Viswanath 
(Eds.), Heath Behavior and Health Education:  Theory, Research, and Practice 
(4th ed., pp. 67-96). Retrieved from http://www.mdquit.org/health-behavior 
Nguyen, MS, K., Marshall, MPH, L., Hu, DrPH, S., & Neff, PhD, L. (2015, May 22, 
2015). State-Specific Prevalence of Current Cigarette Smoking and Smokeless 
Tobacco Use Among Adults Aged >18 Years- United States, 2011-2013. 
Morbidity and Mortality Weekly Report, 64, 532-536. Retrieved from 
www.cdc.gov/mmwr/annual_data/2013 
Parry, O., Thompson, C., & Fowkes, F. R. (2001, April 18, 2001). Dependent behaviors 
and beliefs:  a qualitative study of older long-term smokers with arterial disease. 
Addiction, 96(7), 1337-1347. http://dx.doi.org/10.1080/09652140120070391 
Powell, J. T. (1998). Vascular damage from smoking:  disease mechanisms at the arterial 
wall. Retrieved from http.//vmj.sagepub.com/content/3/1/21.full.pdf 
Rajaee, S., Cherkassky, L., Marcaccio, Jr., E. J., Carney, Jr., W. I., Chong, T., Garcia-
Toca, M., & Slaiby, J. M. (2014, February 18, 2014). Open Revascularization 
Procedures Are More Likely To Influence Smoking Reduction Than Percutaneous 
Procedures. Annals Of Vascular Surgery, 28(), 990-998. 
http://dx.doi.org/10.1016/i.avsg.2013.05.017 
43 
	
Ronayne, RN, MScA, R., O’Connor, RN, PhD, A., & Scobie, MD, FRCS(C), T. K. 
(1989). Smoking:  a decision-making dilemma for the vascular patient. Journal of 
Advanced Nursing, 14(5), 647-652. 
Tahiri, MD, M., Mottillo, MD, S., Joseph, PhD, L., & Pilote, MD, MPH, PhD, L. (2012). 
Alternative Smoking Cessation Aids:  A Meta-analysis of Randomized Controlled 
Trails. The American Journal of Medicine, 125(7), 576-584. 
http://dx.doi.org/10.1016/j.amjmed.2011.09.028 
Weinberger, A. H., Pilver, C. E., Mazure, C. M., & McKee, S. A. (2014). Stability of 
smoking status in the US population:  a longitudinal investigation. Addiction, 109, 
1541-1553. http://dx.doi.org/10.1111/add.12647 
Wu, P., Wilson, K., Dimoulas, P., & Mills, E. J. (2006, December 11, 2006). 
Effectiveness of smoking cessation therapies:  a systematic review and meta-
analysis. BMC Public Health, 6(300), 1-16. http://dx.doi.org/10.1186/1471-2458-
6-300 
 
 
